The Quality Council of India has tied up with the Department of Tourism and various Indian high commissions to boost the export of Ayurvedic products. These agencies will promote Ayurvedic products and institutions certified by QCI in the overseas market.
The QCI is also in talks with the Drug Controller General of India for bringing in necessary regulations to ensure sale of certified products in the domestic market.
The QCI in collaboration with the Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), had recently introduced Ayush Mark quality certification. Till now Ayush mark has been conferred on one hospital and a few products of seven dcompanies. While six other hospitals and most of the leading Ayurvedic product manufacturers have applied for the mark, QCI and AYUSH are in the process of promoting the certification.
“Reports about traces of heavy metal and toxic elements in some Ayurvedic products had raised concerns among the domestic as well as global consumers of Ayurvedic medicines. To allay these fears and promote the system, we have come out with the Ayush mark and certification scheme to determine the composition of the products as well as the treatment standards of Ayurvedic hospitals,” Girdhar J Gyani, secretary general of QCI told Financial Chronicle.
“While we will work towards increasing awareness about the mark among the manufacturers and consumers, the Tourism Department and Indian high commissions will help promote it abroad,” he said.
Tourism department has agreed to promote Ayurvedic drugs, hospitals and spas as well as allopathy hospitals under its ‘Incredible India’ campaign. Similarly all the Indian high commissions abroad will increase awareness about the certification through their websites.
The QCI plans to spend Rs five crore annually for the promotion of the new certification. “We have also asked DCGI to bring in necessary regulations to ensure that only certified drugs are sold in the domestic market. Such a measure will help speedy acceptance of the certification,” he said.
Source:Pharmabiz
No comments:
Post a Comment